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Abstract
Background: The purpose of this study was to compare laboratory and clinical outcomes of intracytoplasmic
morphologically selected sperm injection (IMSI) and conventional intracytoplasmic sperm injection (ICSI) in couples
with repeated implantation failures.
Methods: A total of 200 couples with at least two prior unsuccessful ICSI cycles were enrolled: 100 couples were
submitted to IMSI and 100 were submitted to routine ICSI. For IMSI, spermatozoa were selected at 8400×
magnification using an inverted microscope equipped with Nomarski (differential interference contrast) optics. For
conventional ICSI, spermatozoa were selected at 400× magnification. Clinical outcomes were evaluated between
the two groups.
Results: Study patients were comparable in age, number of treatment failures, aetiology of infertility, percentage of
normal form assessed by MSOME (motile sperm organelle morphology examination), semen parameters, total
number of oocytes collected, number of mature oocytes collected, total number of embryos transferred and
number of high-quality embryos transferred. No statistically significant differences between the two groups were
observed with regard to rates of fertilisation, implantation and pregnancy/cycle. Although not statistically
significant, rates of miscarriage (IMSI:15.3% vs ICSI:31.7%), ongoing pregnancy (IMSI:22% vs ICSI:13%) and live births
(IMSI:21% vs ICSI:12%) showed a trend towards better outcomes in the IMSI group. In addition, analysis of
subpopulations with or without male factor showed similar results.
Conclusions: Our results suggest that IMSI does not provide a significant improvement in clinical outcome
compared to ICSI, at least in couples with repeated implantation failures after conventional ICSI. However, it should
be noted that there were clear trends for lower miscarriage rates (≈50% reduced) and higher rates of ongoing
pregnancy and live births (both nearly doubled) within the IMSI group. Further confirmation as well as randomized
large-scale trials are needed to confirm the beneficial effects of IMSI in couples with poor reproductive prognoses.
Background
Implantation failure is the major cause negatively influen-
cing the outcome of assisted reproductive technologies
(ART), as only two out of every ten embryos successfully
implant [1]. The outcome of intracytoplasmic sperm
injection (ICSI) has been shown to be positively asso-
ciated with the morphological state of the sperm [2-7],
while early miscarriage rates were negatively associated
with nuclear morphology [5-7]. However, repeated failure
of conventional IVF has been suggested to be caused by a
paternal effect on early embryo development, a hypoth-
esis confirmed using a shared oocyte donation model
[8-11].
Bartoov et al. [5,12] developed a method of human
spermatozoa evaluation performed in real-time at high
magnification called “motile sperm organelle morphol-
ogy examination” (MSOME). MSOME is performed
using an inverted microscope equipped with Normarski
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interference contrast optics, which enables observation
at high magnification (> 6000×) compared to the 200-
400× observed by conventional ICSI [12]. This method
led to the development of the intracytoplasmic morpho-
logically selected sperm injection (IMSI) procedure,
which is based on sperm normality as defined by
MSOME classification and aims to improve conven-
tional ICSI outcomes by focusing on the correlation
between abnormalities in sperm morphology observed at
high magnification and DNA damage [5,13-20]. Various
studies have demonstrated that IMSI significantly
improves fertilisation rates [21,22], embryo quality
[5,11,20,21,23], the rate of development up to the blas-
tocyst stage [21,24], the rates of implantation and preg-
nancy after embryo transfer on day 2 or 3
[5-7,11,13,20,22,23,25,26] or in the blastocyst stage
[24,27] and the likelihood of having a normal healthy
child [28]; IMSI also appears to significantly decrease
miscarriage rates [5-7,13,23,26,29]. In fact, prior failures
in ICSI cycles constituted an inclusion criterion in sev-
eral studies employing IMSI [6,13,24,28,30].
To better comprehend the value of IMSI/MSOME, the
purpose of this study was to compare laboratory and
clinical outcomes of IMSI versus conventional ICSI in
couples with repeated ICSI failures.
Materials and methods
Study participants
A total of 200 couples with at least two prior implanta-
tion failures were prospectively evaluated. Patients were
divided into two groups matched by (female) age:
Group ICSI: 100 patients submitted to conventional
ICSI.
Group IMSI: 100 patients submitted to IMSI.
All couples enrolled in the study met the following
inclusion criteria: subfertility with a need for assisted
reproduction with ejaculated spermatozoa, two or more
failed ICSI attempts with embryos of good morphological
quality (four identical blastomeres isolated 44 h after
sperm injection with no fragments or multinucleation
present [31-33]), a maternal age ≤39 years, a normal kar-
yotype in both partners and negative for uterine defects,
ultrasonographic evidence of hydrosalpinx, evidence of
low ovarian response in previous treatment cycles (less
than four oocytes retrieved), infections, endocrine pro-
blems, coagulation defects or thrombophilia and autoim-
mune defects (including antiphospholipid antibodies).
The division between groups was performed as follows:
after referral of the patient for IMSI, the subsequent
patient with the same characteristics (i.e., least two
implantation failures, same age (± 1 year) and fulfilled
the inclusion criteria) was referred for ICSI. Written
informed consents were obtained from all couples, and
this study was approved by an internal institutional
review board.
Ovarian stimulation and oocyte recovery culture protocol
All patients were submitted to the same scheme of con-
trolled ovarian stimulation. First, pituitary downregula-
tion was established with nafarelin acetate at a dose of
400 mg/day (Synarel®; Pfizer, Brazil) started during the
luteal phase of the previous cycle. After 14 days of treat-
ment with the GnRH analogue and after a confirmation
of downregulation, the administration of recombinant
FSH (Gonal F®; Serono Barueri, SP, Brazil) was initiated
at a dose of 150-250 IU, depending on patient age, and
75 IU/day of recombinant LH (Luveris®, Serono, SP,
Brazil) for a period of 7 days. When one or more folli-
cles measuring ≥17 mm were observed, recombinant
HCG (Ovidrel®; Serono, Brazil) was administered at a
dose of 250 μg, and oocyte retrieval was scheduled
35-36 hours later.
Semen preparation
Semen samples were collected in sterile containers by
masturbation after a sexual abstinence period of 2 to 5
days. The liquefied, fresh semen samples were prepared
using ISolate (Irvine Scientific, Santa Ana, CA, USA) dis-
continuous concentration gradient. The final pellet was
resuspended in 0.2 mL of modified HTF medium (Irvine
Scientific, Santa Ana, CA, USA) supplemented with 10%
human serum albumin (Irvine Scientific, Santa Ana, CA,
USA).
Each semen sample was analysed for morphology
according to the MSOME criteria [12] and for standard
semen quality parameters according to the World
Health Organisation[34].
ICSI procedure
Conventional ICSI was performed using a Nikon Eclipse
TE 300 inverted microscope equipped with Narishige
231 D-2 (Narishige, Tokyo, Japan) remote control
hydraulic micromanipulators and Narishige IM-9B injec-
tors. Spermatozoa were selected at 400× magnification
using Hoffman modulation contrast following a set of
published guidelines.
IMSI procedure
A 1-μL aliquot of sperm cell suspension was transferred
to a 5-μL microdroplet of modified HTF medium con-
taining 7% polyvinylpyrrolidone solution (PVP medium
Irvine Scientific, USA). The microdroplet was placed
into a sterile glass dish (FluoroDish™ Word Precision
Instrument, USA) under sterile paraffin oil (Ovoil-100,
Vitrolife, Goteborg, Sweden). Sperm cells suspended
within the microdroplet were placed on a microscope
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stage above an Uplan Apo 100 oil/1.35 objective lens
previously covered by a droplet of immersion oil. In this
manner, suspended motile sperm cells in the observa-
tion droplet could be examined at high magnification
through an inverted microscope (Eclipse TE 2000 U
Nikon, Japan) equipped with high-powered differential
interference contrast optics (DIC/Nomarski). Images
were captured using a colour video camera containing
effective picture elements (pixels) for high-quality image
production and projected onto a colour video monitor.
Morphological evaluation was accomplished using a
monitor screen, and the total calculated magnification
was 8400× (total magnification: objective magnification =
100×, magnification selector = 1.0×, video coupler mag-
nification = 1.0×, calculated video magnification =
84.50×).
A spermatozoon used for IMSI was classified as mor-
phologically normal if it exhibited a normal nucleus as
well as an acrosome, a post-acrosomal lamina, a neck
and a tail, and did not present a cytoplasmic droplet or
cytoplasm around the head [12]. The subcellular orga-
nelles were morphologically classified based on the pre-
sence of specific malformations, which were defined
according to the arbitrary descriptive approach reported
by Bartoov et al. [12] after studies utilising transmission
and scanning electron microscopy. According to trans-
mission electron microscopy estimations [6,12], a mor-
phological normal state for the nucleus was defined by
the shape and content of the chromatin. The criterion
for normality of nuclear form was a smooth, symmetric
and oval configuration. Normal means for length and
width were estimated as 4.75 ± 2.8 and 3.28 ± 0.20 μm
[12], respectively, and the form was classified as abnor-
mal when it presented a variation of 2 standard devia-
tions in one of the axes (length: ≥5.31 or ≤4.19 μm;
width: > 3.7 or < 2.9 μm). For rapid evaluation of
nuclear form, a fixed, transparent, celluloid form of a
sperm nucleus fitting the criteria was superimposed on
the examined cell (chablon construction based on
ASTM E 1951-2 [35]). In the same manner, the nuclear
form was considered abnormal if extrusion or invagina-
tion of the nuclear chromatin mass was detected (regio-
nal malformation of nuclear form). Chromatin content
was considered abnormal if one or more vacuoles were
observed to occupy more than 4% of the nuclear area
(visual evaluation was aided by a celluloid form of a
large vacuole superimposed on the examined cell, if
necessary). A nucleus was considered normal if both
nuclear form and chromatin content were normal.
The same technician performed all sperm selection,
and only normal spermatozoa were injected in this
study. The time involved in the selection step was 30-
120 min/sample, and at least three spermatozoids were
selected for each MII oocyte. After sperm selection,
microinjections were carried out in the same manner as
in ICSI. Spermatozoids were still motile when captured
for final selection.
Oocyte and embryo culture and transfer
Sperm-injected oocytes, zygotes and embryos from both
IMSI and ICSI groups were submitted to the same cul-
ture conditions. On day 2, the two/three best-scoring
embryos from both ICSI and IMSI groups were trans-
ferred. The quality of transferred embryos was similar
between the groups.
Statistical analysis
Data were analysed using InStat version 3.0 (GraphPad
Software, San Diego California, USA) on a Macintosh
computer (Apple Computer Inc., Cupertino, California,
USA). The primary endpoint of the investigation was
the ongoing pregnancy rate and secondary endpoints
were the rates of fertilisation, clinical pregnancy per
cycle, miscarriage and live births. Fertilisation was
defined as zygotes containing two pronuclei after ICSI
or IMSI. Pregnancy was defined as the presence of a
gestational sac with heartbeat visualized by ultrasound
4-6 weeks after embryo transfer. Miscarriage was
defined as the termination of the pregnancy up to 20
weeks of gestation. The variables were analysed in rela-
tion to the general population as well as the subpopula-
tions with or without male factor. The sample size for
the general study was calculated by comparing between
two proportions: control (ICSI cycles) and experimental
(IMSI cycles). In general, the mean ongoing pregnancy
rate was 25%. Thus, a sample size of 100 patients in
each group had 80% power to detect an increase of 20%
with an alpha significance level of 0.05 (two-tailed).
When appropriate, Student’s t-tests, Mann-Whitney
tests and chi-square tests were utilised with a signifi-
cance level of P < 0.05.
Results
The characteristics of the study patients (general popula-
tion) in both the IMSI and ICSI groups were comparable
with regard to age, the number of treatment failures,
aetiology of infertility, the percentage of normal form
assessed by MSOME, semen parameters, the total num-
ber of oocytes collected, the number of mature oocytes
collected, the total number of embryos transferred and
the number of high-quality embryos transferred. No sta-
tistically significant differences (P > 0.05) were observed
between the two groups with regard to rates of fertilisa-
tion (IMSI: 65.4 ± 23.5%; ICSI: 62 ± 26.5%), implantation
(IMSI:13.6%; ICSI:9.8%) and pregnancy/cycle (IMSI:26%;
ICSI:19%). Although not statistically significant, rates of
miscarriage (IMSI:15.4%; ICSI:31.6%), ongoing pregnancy
(IMSI:22%; ICSI:13%) and live births (IMSI:21%;
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ICSI:12%) displayed a clear trend towards better out-
comes in the IMSI group. Table 1 summarises the char-
acteristics and outcomes of the general study population.
In the subpopulation of cases with male factor (IMSI:
37 couples; ICSI: 45 couples) characteristics of study
patients were comparable with regard to age, the num-
ber of treatment failures, the percentage of normal form
assessed by MSOME, semen parameters, the total num-
ber of oocytes collected, the number of mature oocytes
collected, the total number of embryos transferred and
the number of high-quality embryos transferred. Similar
to the general population, no statistically significant dif-
ferences (P > 0.05) were observed between the two
groups with regard to rates of fertilisation (IMSI: 59.1 ±
23.1%; ICSI: 57.8 ± 25.2%), implantation (IMSI: 11.8%;
ICSI: 11.2%) and pregnancy/cycle (IMSI: 32.4%; ICSI:
24.4%). Rates of miscarriage (IMSI: 16.7%; ICSI: 36.4%),
ongoing pregnancy (IMSI:27%; ICSI: 15.5%) and live
births (IMSI:27%; ICSI: 15.5%) again showed a clear
trend towards better outcomes in the IMSI group,
although they were not considered statistically signifi-
cant. These results are summarised in Table 2.
In relation to the subpopulation without male factor
(IMSI: 63 couples; ICSI: 55 couples), there were no dif-
ferences in patient age, the number of treatment fail-
ures, the percentage of normal form assessed by
MSOME, semen parameters, the total number of
oocytes collected, the number of mature oocytes col-
lected, the total number of embryos transferred and the
number of high-quality embryos transferred between the
two groups. Once again, no differences (P > 0.05) were
observed in rates of fertilisation (IMSI: 68.1 ± 24.4%;
Table 1 General study population; comparison between morphologically selected sperm injection (IMSI) and
conventional intracytoplasmic sperm injection (ICSI) groups
Total
IMSI ICSI P
Cycles (n) 100 100
Female age (years) 36.8 ± 3.9 36.7 ± 4.0 0.80
Male age (years) 39.8 ± 6.2 40.3 ± 6.0 0.50
Number of failures 3.3 ± 1.7 3.2 ± 1.6 0.49
Aetiology (%)




Male + endometriosis 6 2
Tuboperitoenal+ endometriosis 2 6
Male+tuboperitoneal 2 8
MSOME a
Normal spermatozoa (%) 1.5 ± 1.8 1.7 ± 1.8 0.32
Semen Parameters b
Total sperm count (x106/mL) 70.4 ± 83.4 70.7 ± 60.4 0.97
Motility (% spermatozoa) (rapid + slow progression) 51.8 ± 19.7 49.6 ± 23.7 0.55
Vitality (%) (mean ± SD) 60.5 ± 17.4 56.0 ± 16.9 0.20
Leukocytes in semen (x106) (mean ± SD) 0.4 ± 0.6 0.5 ± 0.4 0.22
Number of oocytes
Mature (MII) 7.1 ± 4.8 6.7 ± 3.5 0.94
Total 9.5 ± 6.2 8.4 ± 4.6 0.45
Fertilisation rate (%) 65.4 ± 23.5 62 ± 26.5 0.34
Embryos transfer (n) 2.7 ± 1.0 2.7 ± 1.0 0.44
High-quality embryo transfer (n) 1.4 ± 0.5 1.5 ± 0.5 0.53
Implantation rate (%) 13.6 9.8 0.21
Pregnancy/cycle (%) 26 19 0.73
Miscarriage (%) 15.4 31.6 0.28
Ongoing pregnancy/cycle (%) 22 13 0.13
Live birth/cycle (%) 21 12 0.12
a motile sperm organelle morphology examination
b semen quality parameters according to the World Health Organisation[34]
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ICSI: 65.4 ± 27.4%), implantation (IMSI: 14.6%; ICSI:
8.6%) or pregnancy/cycle (IMSI: 22.2%; ICSI: 14.5%). As
in previous analyses, rates of miscarriage (IMSI: 14.3%;
ICSI: 25%), ongoing pregnancy (IMSI: 19%; ICSI: 10.9%)
and live births (IMSI: 17.5%; ICSI: 9.1%) displayed a
clear trend towards better outcomes in the IMSI group,
although they were not statistically significant. These
results are summarised in Table 2.
Discussion
The aim of ART is to birth a single, healthy baby, and the
success of this event depends on many variables. Despite
advances in the field of assisted reproduction, implanta-
tion rates have not improved significantly since the ICSI
technique was established in 1992 [36]. It is well known
that implantation rates are related to endometrial recep-
tivity, cytokines, and growth factors secreted by ovarian
stimulation [37-39]. Poor embryo quality is another
important factor that negatively affects implantation rates
[40]. Choosing sperm using MSOME parameters appears
to provide better rates of fertilisation and embryo quality
[11,21], which also translates to better conditions during
the implantation process. It is well established that the
capacity of human sperm to fertilise an oocyte and pro-
duce an embryo with high potential of implantation and
development depends, among other factors, on DNA
integrity [15,16]. Observations from our group have
shown that the presence of large nuclear vacuoles (LNV),
which are sperm-specific alterations observed at high
magnification, may be related to DNA fragmentation and
Table 2 Subpopulations with or without male factor; comparison between morphologically selected sperm injection
(IMSI) and conventional intracytoplasmic sperm injection (ICSI) study groups
With male factor Without male factor
IMSI ICSI P IMSI ICSI P
Cycles (n) 37 45 63 55
Female age (years) 36.9 ± 4.0 35.6 ± 3.9 0.11 36.6 ± 4.0 37.7 ± 3.9 0.13
Male age (years) 40.6 ± 6.4 41.9 ± 6.5 0.34 39.3 ± 6.0 39.0 ± 5.3 0.79
Number of failures 3.1 ± 1.6 3.4 ± 1.9 0.64 3.4 ± 1.7 3.0 ± 1.3 0.20
Aetiology (%)
Male 78.4 77.8 0.08 0.33
Idiopathic 0 0 38 30.9
Tuboperitoneal 0 0 30.2 25.4
Endometriosis 0 0 28.6 32.7
Male + endometriosis 16.2 4.4 0 0
Tuboperitoenal+ endometriosis 0 0 3.2 11
Male+tuboperitoneal 5.4 17.8 0 0
MSOME a
Normal spermatozoa (%) 0.3 ± 0.3 0.3 ± 0.3 0.79 2.4 ± 1.9 2.5 ± 2.1 > 0.99
Semen Parameters
Total sperm count (x106/mL) 14.2 ± 18.4 11.8 ± 14.9 0.86 95.8 ± 88.9 98.9 ± 52.5 0.82
Motility (% spermatozoa) 35.5 ± 14.1 29.6 ± 15.6 0.12 60.9 ± 16.2 61.1 ± 10.8 0.94
(rapid+slowprogression) 49.6 ± 15.8 47.2 ± 15.2 0.54 65.5 ± 15.9 70 ± 6.3 0.56
Vitality (%) (mean ± SD) 0.3 ± 0.3 0.4 ± 0.5 0.21 0.4 ± 0.8 0.5 ± 0.3 0.16
Leukocytes in semen (x106) (mean ± SD)
Number of oocytes
Mature (MII) 8.0 ± 5.1 7.8 ± 3.7 0.82 6.6 ± 4.4 5.9 ± 3.1 0.56
Total 10.7 ± 6.8 9.4 ± 4.6 0.61 8.7 ± 5.7 7.6 ± 4.4 0.44
Fertilisation rate (%) 59.1 ± 23.1 57.8 ± 25.2 0.61 68.1 ± 24.4 65.4 ± 27.4 0.72
Embryos transfer (n) 2.6 ± 1.0 2.8 ± 1.1 0.69 2.7 ± 1.1 2.6 ± 1.0 0.63
High-quality embryo transfer (n) 1.5 ± 0.5 1.5 ± 0.5 0.89 1.4 ± 0.5 1.5 ± 0.5 0.55
Implantation rate (%) 11.8 11.2 0.88 14.6 8.6 0.16
Pregnancy/cycle (%) 32.4 24.4 0.57 22.2 14.5 0.40
Miscarriage (%) 16.7 36.4 0.54 14.3 25 0.95
Ongoing pregnancy/cycle (%) 27 15.5 0.31 19 10.9 0.33
Live birth/cycle (%) 27 15.5 0.31 17.5 9.1 0.29
a motile sperm organelle morphology examination
b semen quality parameters according to the World Health Organisation[34]
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denaturation [15]. Vanderzwalmen et al. [24] also
reported a negative impact of the presence of one large
nuclear vacuole or several small vacuoles in the head of
spermatozoa on the competence of embryos to develop
to the blastocyst stage. Moreover, Wilding et al. [20] had
suggested that a correlation exists between LNV and
DNA fragmentation. Even if percentages of fertilisation
and embryo development are comparable to those of
conventional ICSI, embryos obtained from spermatozoa
analysed by MSOME showed higher quality, and more
overall pregnancies were achieved. On the other hand,
recent investigations have related LNV to the absence of
an acrosome reaction, which could explain the hamper-
ing of embryo development when a spermatozoon with
this characteristic is chosen for microinjection [41].
Gopalkrishnan et al. [42] found that the chromatin of
spermatozoa from men whose partners presented with
early pregnancy loss was often compact or partially com-
pact with irregular nuclear borders and large vacuoles.
Currently, ICSI is performed after morphological selec-
tion of spermatozoa at 200× to 400× magnification. In
this magnification range, spermatozoa carrying defects of
the head, neck or tail can be detected, but nuclear
vacuoles cannot. Therefore, observation at a magnifica-
tion of 6000× to 12,500× when selecting spermatozoa
appears to be better by simply allowing precise identifica-
tion of vacuoles [6,7,15,16,20,23,24]. Nevertheless, in
couples with repeated implantation failures, sperm selec-
tion at high magnification does not appear to exert much
significant influence. Fertilisation rates were similar
between the IMSI and ICSI groups, a result not influ-
enced by the presence or absence of male factor, and
confirms other prior findings that also did not detect any
significant differences in fertilisation rates [5,11,12,23].
Regarding clinical results, there was again no significant
influence of sperm selection at high magnification both
in the general population and in subgroups with or with-
out male factor. However, there was a significant and
clear trend for better results in the IMSI group, particu-
larly for rates of ongoing pregnancy, live births (both
nearly doubled) and miscarriage (≈50% reduced).
Although not statistically significant (likely due to sample
size), these results can be considered clinically relevant.
Given that apparently normal spermatozoa visualized in
the low magnification range in conventional ICSI may
possess hidden anomalies that could be detected at
higher magnification with MSOME, the use of sperm
selected by IMSI can produce embryos with higher devel-
opmental capacity. This would exclude using sperm
with higher probabilities of DNA fragmentation and
denaturation.
This trend is in agreement with several published stu-
dies. In addition, other investigations reported that IMSI is
able to increase pregnancy rates and reduce miscarriage
rates in assisted reproduction cycles [5,11,14,20,23,26]. In
a prospective randomized study comparing the clinical
outcome of 87 IMSI cycles with 81 conventional ICSI
cycles, Balaban et al. [25] reported that IMSI did not pro-
vide any significant improvement in the clinical outcome
compared to ICSI. However, there were trends for higher
rates of implantation (28.9% versus 19.5%), clinical preg-
nancy (54.0% versus 44.4%) and live births (43.7% versus
38.3%) in the IMSI group. On the other hand, in this same
study [25], severe male factor patients were found to bene-
fit from the IMSI procedure, as significantly higher
implantation rates were observed compared to their coun-
terparts in the ICSI group.
In conclusion, the results obtained in this investigation
suggest that IMSI does not appear to provide a significant
improvement in clinical outcome compared to ICSI, at
least in couples with repeated implantation failures after
conventional ICSI. However, it should be noted that there
were clear trends for lower rates of miscarriage (≈50%
reduced) and higher ongoing pregnancy and live births
(nearly doubled) in the IMSI group. Thus, using morpho-
logically-selected spermatozoa with IMSI would benefit
those with poor reproductive prognosis; however, further
confirmation in addition to randomized large-scale trials
are still needed.
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